Efficiency of quercetin and trimetazidine in patients with COVID-19 and concomitant chronic coronary syndrome: Effect on systemic inflammation | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Efficiency of quercetin and trimetazidine in patients with COVID-19 and concomitant chronic coronary syndrome: Effect on systemic inflammation

Authors:: I. V. Tomyn; S. V. Fedorov

Reference:: Bulletin of Problems Biology and Medicine; 2024; 173; 274-280

DOI:: 10.29254/2077-4214-2024-2-173-274-280

See Abstract

Key Words:: Clinical study; randomization; open-label; controlled study; parallel-group; COVID-19; chronic coronary syndrome; quercetin; trimetazidine; systemic inflammatory response index; aggregate index of systemic inflammation

Back to index